We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.9B
AUM Growth
+$1.9B
Cap. Flow
+$442M
Cap. Flow %
3.42%
Top 10 Hldgs %
34.89%
Holding
1,323
New
145
Increased
499
Reduced
420
Closed
63

Top Buys

Rank Stock Value
1
COLD icon
Americold
COLD
+$166M
2
OHI icon
Omega Healthcare
OHI
+$102M
3
SUI icon
Sun Communities
SUI
+$98.2M
4
AIRC
Apartment Income REIT Corp.
AIRC
+$97.3M
5
DOC icon
Healthpeak Properties
DOC
+$93.5M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$261M
2
PLD icon
Prologis
PLD
+$67.9M
3
KRC icon
Kilroy Realty
KRC
+$67.2M
4
WELL icon
Welltower
WELL
+$62.1M
5
STOR
STORE Capital Corporation
STOR
+$56.9M

Sector Composition

Rank Sector Weight
1 Real Estate 60.68%
2 Technology 7.51%
3 Communication Services 3.68%
4 Healthcare 3.56%
5 Consumer Discretionary 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
1051
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$5K ﹤0.01%
50
-97
-66% -$8.99K
ARCE
1052
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$5K ﹤0.01%
135
-18,856
-99% -$715K
GBT
1053
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5K ﹤0.01%
116
-232
-67% -$11.4K
AMRN
1054
Amarin Corp
AMRN
$297M
$4K ﹤0.01%
36
-64
-64% -$6.17K
CXW icon
1055
CoreCivic
CXW
$2.94B
$4K ﹤0.01%
547
-25,535
-98% -$184K
GRFS
1056
Grifois
GRFS
$5.55B
$4K ﹤0.01%
224
-487
-68% -$9.03K
IGMS
1057
DELISTED
IGM Biosciences
IGMS
$4K ﹤0.01%
+46
New +$3.23K
MCRB icon
1058
Seres Therapeutics
MCRB
$45M
$4K ﹤0.01%
9
-13
-59% -$7.61K
NKTX icon
1059
Nkarta
NKTX
$152M
$4K ﹤0.01%
+61
New +$2.53K
SGMO
1060
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4K ﹤0.01%
266
-536
-67% -$6.28K
STOK icon
1061
Stoke Therapeutics
STOK
$1.84B
$4K ﹤0.01%
68
-117
-63% -$5.36K
YMAB
1062
DELISTED
Y-mAbs Therapeutics
YMAB
$4K ﹤0.01%
76
-148
-66% -$6.85K
ZNTL icon
1063
Zentalis Pharmaceuticals
ZNTL
$332M
$4K ﹤0.01%
+76
New +$3.43K
RVNC
1064
DELISTED
Revance Therapeutics, Inc.
RVNC
$4K ﹤0.01%
125
-192
-61% -$4.97K
NGM
1065
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4K ﹤0.01%
130
-246
-65% -$5.38K
VIE
1066
DELISTED
Viela Bio, Inc. Common Stock
VIE
$4K ﹤0.01%
+103
New +$3.61K
ATRA icon
1067
Atara Biotherapeutics
ATRA
$72.6M
$3K ﹤0.01%
6
-10
-63% -$4.62K
AUPH icon
1068
Aurinia Pharmaceuticals
AUPH
$1.95B
$3K ﹤0.01%
238
-404
-63% -$5.88K
CYTK icon
1069
Cytokinetics
CYTK
$10.6B
$3K ﹤0.01%
133
-230
-63% -$4.2K
GMAB icon
1070
Genmab
GMAB
$17.5B
$3K ﹤0.01%
86
-109
-56% -$4.08K
HCM icon
1071
HUTCHMED
HCM
$1.96B
$3K ﹤0.01%
97
-181
-65% -$5.57K
IBRX icon
1072
ImmunityBio
IBRX
$7.15B
$3K ﹤0.01%
+204
New +$1.96K
INO icon
1073
Inovio Pharmaceuticals
INO
$85.6M
$3K ﹤0.01%
27
-48
-64% -$6.39K
IRWD icon
1074
Ironwood Pharmaceuticals
IRWD
$586M
$3K ﹤0.01%
301
-584
-66% -$6.39K
KROS icon
1075
Keros Therapeutics
KROS
$197M
$3K ﹤0.01%
+44
New +$2.77K
41 42
43
44 45

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q4 2020 Portfolio in Review

As of Q4 2020, Daiwa Securities Group held 1,323 positions worth $12.9B, up 17% from $11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $442M of net new capital in Q4 2020, opening 145 new positions and adding to 499 existing holdings. Its largest new stake was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Equinix, an estimated $261M trimmed.

  • Daiwa Securities Group's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.
  • Daiwa Securities Group added most to Americold in Q4 2020, an estimated $166M increase.
  • Daiwa Securities Group's biggest Q4 2020 reduction was Equinix, cutting an estimated $261M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 6.219% Corporate Units in Q4 2020, selling an estimated $16.6M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12.9B portfolio in Q4 2020.
  • Daiwa Securities Group opened 145 new positions and closed 63 in Q4 2020.
  • Daiwa Securities Group's portfolio value rose 17% quarter-over-quarter to $12.9B.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.